Skip Navigation

Biometrika 1981 68(3):669-675; doi:10.1093/biomet/68.3.669
© 1981 by Biometrika Trust
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by MEHTA, C. R.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Sequential comparison of two exponential distributions with censored survival data

CYRUS R. MEHTA

Sidney Farber Cancer Institute, Harvard School of Public Health Boston, Massachusetts

A sequential stopping procedure is proposed for a clinical trial which compares two exponential distributions using censored survival data. The procedure extends an approach first developed by Anscombe (1963) for comparing two treatments with normally distributed and instantaneously observed responses. Patients are assumed to arrive at random and are assigned alternately to one of the two treatments. An optimal stopping region for the ratio of failure rates of the two treatments is derived. The optimality criterion is to minimize the posterior expected regret of stopping at each stage. The stopping rule is evaluated by computer simulation and compared with several other stopping rules.

Key Words: Bayesian inference • Censored observation • Clinical trial • Decision theory • Exponential distribution • Optimal stopping • Patient horizon • Sequential analysis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Med Decis MakingHome page
S. G. Baker and K. Heidenberger
Choosing Sample Sizes to Maximize Expected Health Benefits Subject to a Constraint on Total Trial Costs
Med Decis Making, February 1, 1989; 9(1): 14 - 25.
[Abstract] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.